The 15 references in paper A. Beltiukova S., K. Syssoev A., T. Il’ina N., T. Shemerovskaya G., M. Hobeish M., K. Monakhov N., Areg Totolian A., А. Бельтюкова С., К. Сысоев А., Т. Ильина Н., Т. Шемеровская Г., М. Хобейш М., К. Монахов Н., Арег Тотолян А. (2014) “ЭКСПРЕССИЯ мРНК ХЕМОКИНОВ И ХЕМОКИНОВЫХ РЕЦЕПТОРОВ В КОЖЕ БОЛЬНЫХ ПСОРИАЗОМ // EXPRESSION OF mRNAS FOR CHEMOKINES AND CHEMOKINE RECEPTORS IN THE SKIN FROM PATIENTS WITH PSORIASIS” / spz:neicon:mimmun:y:2008:i:5:p:337-346

1
Коган К.М. Спектр клинических проявлений псориатического артрита: Метод. рекомендации. – М., 2006.
(check this in PDF content)
2
Федосеев Г.Б., Игнатов Ю.Д. Синдромальная диагностика и базисная фармакотерапия заболеваний внутренних органов. Т. 1. – СПб: «Нордмедиздат», 2004. – С. 74-75.
(check this in PDF content)
3
Wewers M.E., Lowe N.K. A critical review of visual analogue scales in the measurement of clinical phenomena // Res. Nurs. Health. – 1990. – Vol. 13. – P. 227-236.
(check this in PDF content)
4
Groot M., Teunissen M.B., Ortonne J.P., Lambert J.R., Naeyaert J.M., Picavet D.I., Arreaza M.G., Simon J.S., Kraan M., Bos J.D., de Rie M.A. Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor // Arch. Dermatol. Res. – 2007. – Vol. 299, N 7. – P. 305-313.
(check this in PDF content)
5
Kang S., Voorhees J.J. Immunopathogenesis // Textbook of psoriasis / Ed. by Van de Kerkhof P. – Oxford: Blackwell Science, 1999. – P. 106-118.
(check this in PDF content)
6
Nickoloff B.J. The immunologic and genetic basis of psoriasis // Arch. Dermatol. – 1999. – Vol. 135. – P. 1104-1110.
(check this in PDF content)
7
Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., Darst M.A., Gao B., Boguniewicz M., Travers J.B., Leung D.Y. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes // J. Immunol. – 2003. – Vol. 171, N 6. – P. 3262-3269.
(check this in PDF content)
8
Godi A. New approaches to psoriasis treatment // Acta Dermatoven. – 2004.– Vol 13, N2. – P. 50-57.
(check this in PDF content)
9
Prinz J.C. Psoriasis vulgaris, a sterile antibacterial skin reaction, mediated by cross-reactive T-cells. An immunological view on the pathophysiology of psoriasis // Clin. Exp. Dermatol. – 2001. – Vol. 26. – P. 326-332.
(check this in PDF content)
10
Schlaak J.F., Buslau M., Jochum W., Hermann E., Girndt M., Gallati H., Meyer zum B- schenfelde K.H., Fleischer B. T cells involved in psoriasis vulgaris belong to the Th1 subset // J. Invest. Dermatol. – 1994. – Vol. 102, N 2. – P. 145-149.
(check this in PDF content)
11
Turka L.A., Goodman R.E., Rutkowski J.L., Sima A.A., Merry A., Mitra R.S., Wrone-Smith T., Toews G., Strieter R.M., Nickoloff B.J. Interleukin
(check this in PDF content)
12
a potential link between nerve cells and the immune response in inflammatory disorders // Mol. Med. – 1995. – Vol. 1, N 6. – P. 690-699. 12. Yawalkar N., Shrikhande M., Hari Y., Nievergelt H., Braathen L.R., Pichler W.J. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions // J. Allergy Clin. Immunol. – 2000. – Vol. 106, N 6. – P. 1171-1176.
(check this in PDF content)
13
Ghoreschi K., Weigert C., Rcken M. Immunopathogenesis and role of T cells in psoriasis // Clin. Dermatol. – 2007. – Vol. 25, N 6. – P. 574-580.
(check this in PDF content)
14
Macchioni P., Boiardi L., Meliconi R., Pulsatelli L., Maldini M.C., Ruggeri R., Facchini A., Salvarani C. Serum chemokines in patients with psoriatic arthritis treated with cyclosporin A // J. Rheumatol. – 1998. – Vol. 25, N 2. – P. 320-325.
(check this in PDF content)
15
Szodoray P., Alex P., Chappell-Woodward C.M., Madland T.M., Knowlton N., Dozmorov I., Zeher M., Jarvis J.N., Nakken B., Brun J.G., Centola M. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a mul-
(check this in PDF content)